In this review:
Real-world glucocorticoid use in early RA
Certolizumab: rapid symptom control in RA
Predicting RA in recent-onset polyarthritis
Validation of clinical parameters for guiding rituximab therapy
ACPA status and treatment response
Please login below to download this issue (PDF)